Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 86

Publication Record

Connections

Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.
Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran TB, Idrees K, Isom CA, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK
(2018) Ann Surg 267: 797-805
MeSH Terms: Adult, Aged, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Female, Follow-Up Studies, Hepatectomy, Humans, Klatskin Tumor, Liver Transplantation, Male, Middle Aged, Patient Selection, Retrospective Studies, Survival Rate, United States
Show Abstract · Added April 10, 2018
OBJECTIVE - To investigate the influence of type of surgery (transplant vs resection) on overall survival (OS) in patients with hilar cholangiocarcinoma (H-CCA).
BACKGROUND - Outcomes after resection for H-CCA are poor, yet transplantation is currently only reserved for well-selected patients with unresectable disease.
METHODS - All patients with H-CCA who underwent resection from 2000 to 2015 at 10 institutions were included. Three institutions additionally had active H-CCA transplant protocols with similar selection criteria over similar time periods.
RESULTS - Of 304 patients with suspected H-CCA, 234 underwent attempted resection and 70 were enrolled in a transplant protocol. Excluding incomplete/R2 resections (n = 43), patients who were enrolled, but did not undergo transplant (n = 24), and transplants without confirmed H-CCA diagnoses (n = 5), 191 patients underwent curative-intent resection and 41 curative-intent transplant. Compared with resection, transplant patients were younger (52 vs 65 years; P < 0.001), and more frequently had primary sclerosing cholangitis (PSC; 61% vs 2%; P < 0.001) and received chemotherapy and/or radiation (98% vs 57%; P < 0.001). Groups were otherwise similar in demographics and comorbidities. Patients who underwent transplant for confirmed H-CCA diagnosis had improved OS compared with resection (3-year: 72% vs 33%; 5-year: 64% vs 18%; P < 0.001). Among patients who underwent resection for tumors <3 cm with lymph-node negative disease, and excluding PSC patients, transplant was still associated with improved OS (3-year: 54% vs 44%; 5-year: 54% vs 29%; P = 0.03). Transplant remained associated with improved survival on intention-to-treat analysis, even after accounting for tumor size, lymph node status, and PSC (P = 0.049).
CONCLUSIONS - Resection for hilar cholangiocarcinoma that meets criteria for transplantation (<3 cm, lymph-node negative disease) is associated with substantially decreased survival compared to transplant for the same criteria with unresectable disease. Prospective trials are needed and justified.
0 Communities
1 Members
0 Resources
16 MeSH Terms
Macrophage IKKα Deficiency Suppresses Akt Phosphorylation, Reduces Cell Survival, and Decreases Early Atherosclerosis.
Babaev VR, Ding L, Zhang Y, May JM, Lin PC, Fazio S, Linton MF
(2016) Arterioscler Thromb Vasc Biol 36: 598-607
MeSH Terms: Animals, Apoptosis, Atherosclerosis, Cell Survival, Cells, Cultured, Diet, Western, Disease Models, Animal, Female, I-kappa B Kinase, Inflammation Mediators, Liver, Liver Transplantation, Macrophages, Peritoneal, Male, Mechanistic Target of Rapamycin Complex 2, Mice, Inbred C57BL, Mice, Knockout, Multiprotein Complexes, Phosphorylation, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Receptors, LDL, Signal Transduction, TOR Serine-Threonine Kinases, Time Factors
Show Abstract · Added February 22, 2016
OBJECTIVE - The IκB kinase (IKK) is an enzyme complex that initiates the nuclear factor κB transcription factor cascade, which is important in regulating multiple cellular responses. IKKα is directly associated with 2 major prosurvival pathways, PI3K/Akt and nuclear factor κB, but its role in cell survival is not clear. Macrophages play critical roles in the pathogenesis of atherosclerosis, yet the impact of IKKα signaling on macrophage survival and atherogenesis remains unclear.
APPROACH AND RESULTS - Here, we demonstrate that genetic IKKα deficiency, as well as pharmacological inhibition of IKK, in mouse macrophages significantly reduces Akt S(473) phosphorylation, which is accompanied by suppression of mTOR complex 2 signaling. Moreover, IKKα null macrophages treated with lipotoxic palmitic acid exhibited early exhaustion of Akt signaling compared with wild-type cells. This was accompanied by a dramatic decrease in the resistance of IKKα(-/-) monocytes and macrophages to different proapoptotic stimuli compared with wild-type cells. In vivo, IKKα deficiency increased macrophage apoptosis in atherosclerotic lesions and decreased early atherosclerosis in both female and male low-density lipoprotein receptor (LDLR)(-/-) mice reconstituted with IKKα(-/-) hematopoietic cells and fed with the Western diet for 8 weeks compared with control LDLR(-/-) mice transplanted with wild-type cells.
CONCLUSIONS - Hematopoietic IKKα deficiency in mouse suppresses Akt signaling, compromising monocyte/macrophage survival and this decreases early atherosclerosis.
© 2016 American Heart Association, Inc.
0 Communities
2 Members
0 Resources
25 MeSH Terms
Living donor liver transplantation from a heterozygous parent for classical maple syrup urine disease.
Kadohisa M, Matsumoto S, Sawada H, Honda M, Murokawa T, Hayashida S, Ohya Y, Lee KJ, Yamamoto H, Mitsubuchi H, Endo F, Inomata Y
(2015) Pediatr Transplant 19: E66-9
MeSH Terms: Amino Acids, Branched-Chain, Fathers, Female, Heterozygote, Humans, Infant, Liver Transplantation, Living Donors, Male, Maple Syrup Urine Disease, Postoperative Period, Treatment Outcome
Show Abstract · Added March 7, 2015
MSUD is a hereditary metabolic disorder that is characterized by impaired activity of the BCKADC. Liver transplantation has been approved as a treatment for some MSUD cases in which the control of BCAAs is insufficient. Although there have been several reports about DDLT for MSUD, few LDLT cases have been reported. Because either of parents who are heterozygote of this disease usually applies to be a candidate of donor in LDLT, the impairment of BCKADC activity of graft liver should be concerned. We performed LDLT for 10 month-old girl with a left lateral segment graft from her father. BCKADC activities of the patient and her parents were measured using lysates of lymphocytes isolated from peripheral blood specimen before the transplant. As a consequence, the activity of BCKADC of father was not inferior to a normal range. The patient tolerated the operation well. Postoperative course was uneventful and mixed milk was started at 8th POD. The serum BCAAs levels have remained within normal range. It should be necessary to follow the physical growth and mental development of the recipient in the future.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
0 Communities
1 Members
0 Resources
12 MeSH Terms
Management of portal vein thrombosis after liver transplantation with a combined open and endovascular approach.
Kensinger CD, Sexton KW, Baron CM, Lipnik AJ, Meranze SG, Gorden DL
(2015) Liver Transpl 21: 132-4
MeSH Terms: Aged, Fibrinolytic Agents, Humans, Infusions, Intravenous, Laparotomy, Liver Diseases, Alcoholic, Liver Transplantation, Male, Phlebography, Portal Vein, Thrombolytic Therapy, Tissue Plasminogen Activator, Tomography, X-Ray Computed, Treatment Outcome, Vascular Patency, Venous Thrombosis
Added February 12, 2015
0 Communities
1 Members
0 Resources
16 MeSH Terms
Single-center experience and long-term outcomes of duct-to-duct biliary reconstruction in infantile living donor liver transplantation.
Yamamoto H, Hayashida S, Asonuma K, Honda M, Suda H, Murokawa T, Ohya Y, Lee KJ, Takeichi T, Inomata Y
(2014) Liver Transpl 20: 347-54
MeSH Terms: Anastomosis, Roux-en-Y, Bile Ducts, Body Weight, Child, Preschool, Cholangiography, Cholangitis, Cholestasis, End Stage Liver Disease, Female, Follow-Up Studies, Humans, Infant, Liver Transplantation, Living Donors, Male, Treatment Outcome
Show Abstract · Added February 11, 2015
The indications for duct-to-duct (DD) biliary reconstruction in living donor liver transplantation (LDLT) for small children are still controversial. In this study, the feasibility of DD biliary reconstruction versus Roux-en-Y (RY) biliary reconstruction was investigated in terms of long-term outcomes. Fifty-six children who consecutively underwent LDLT with a weight less than or equal to 10.0 kg were enrolled. Biliary reconstruction was performed in a DD fashion for 20 patients and in an RY fashion for 36 patients. During a minimum follow-up of 2 years, the incidence of biliary strictures was 5.0% in the DD group and 11.1% in the RY group. Cholangitis during the posttransplant period was observed in the RY group only. There were no deaths related to biliary problems. This study shows that DD reconstruction in LDLT for small children (weighing 10.0 kg or less) is a feasible option for biliary reconstruction.
© 2014 American Association for the Study of Liver Diseases.
0 Communities
1 Members
0 Resources
16 MeSH Terms
False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review.
Taguchi K, Ohmura T, Ohya Y, Horio M, Furukawa K, Jono H, Inomata Y, Saito H
(2014) Exp Clin Transplant 12: 474-8
MeSH Terms: Aged, Drug Monitoring, False Positive Reactions, Female, Humans, Immunoassay, Immunosuppressive Agents, Liver Transplantation, Magnetics, Middle Aged, Predictive Value of Tests, Reproducibility of Results, Tacrolimus, Time Factors, Treatment Outcome
Show Abstract · Added February 11, 2015
Safe use of tacrolimus relies on regular whole-blood drug monitoring. Of the methods used to assess whole-blood tacrolimus concentration, antibody-conjugated magnetic immunoassay is mostly used for therapeutic drug monitoring because it requires only a minimal sample preparation and no pretreatment procedure. However, several cases recently have been reported in which abnormally false elevated tacrolimus concentrations were measured by antibody-conjugated magnetic immunoassay (>15 ng/mL), despite the absence of clinical symptoms. We present 2 cases of falsely detected tacrolimus concentrations that did not show abnormally high values within the therapeutic range. Whole-blood tacrolimus concentrations obtained by antibody-conjugated magnetic immunoassay showed well-controlled concentrations (approximately 2-8 ng/mL), whereas those obtained by another immunoassay and in washed erythrocytes were below the assay range (< 1.2 ng/mL). Thus, antibody-conjugated magnetic immunoassay can elicit falsely positive results of tacrolimus concentrations, even though they are within the therapeutic range.
0 Communities
1 Members
0 Resources
15 MeSH Terms
Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.
Oshima T, Kawahara S, Ueda M, Kawakami Y, Tanaka R, Okazaki T, Misumi Y, Obayashi K, Yamashita T, Ohya Y, Ihse E, Shinriki S, Tasaki M, Jono H, Asonuma K, Inomata Y, Westermark P, Ando Y
(2014) J Neurol Neurosurg Psychiatry 85: 740-6
MeSH Terms: Adult, Amyloid, Amyloid Neuropathies, Familial, Coloring Agents, Congo Red, Female, Humans, Liver Transplantation, Male, Mass Spectrometry, Middle Aged, Myocardium, Prealbumin, Spinal Cord, Time Factors, Tongue
Show Abstract · Added February 11, 2015
OBJECTIVE - To elucidate the long-term effects of liver transplantation (LT) on familial amyloid polyneuropathy (FAP).
METHODS - We investigated clinicopathological and biochemical characteristics of systemic tissues in four autopsied cases of FAP patients surviving more than 10 years after LT and seven autopsied cases without LT. For analysing the truncated form of transthyretin (TTR) in amyloid, we also employed specimens from additional 18 FAP patients.
RESULTS - Several tissue sites such as the heart, tongue and spinal cord had moderate-to-severe amyloid deposits but other tissues showed no or mild amyloid deposition. Those findings seemed similar to those observed in senile systemic amyloidosis (SSA), a sporadic amyloidosis caused by wild-type (WT) TTR. Also, amyloid deposits in systemic tissue sites except for the spinal cord in patients after LT derived mostly from WT TTR secreted from the normal liver grafts. In addition, in non-transplantation patients, proportions of WT TTR seemed to be relatively high in those tissue sites in which patients after LT had severe amyloid deposition, which suggests that WT TTR tends to form amyloid in those tissue sites. Finally, although the truncation of TTR in amyloid deposits did not depend on undergoing LT, we elucidated the truncation of TTR occurred predominantly in patients from non-endemic areas of Japan, where FAP amyloidogenic TTR V30M patients are late onset and low penetrance, compared with patients from an endemic area of Japan.
CONCLUSIONS - FAP may shift to systemic WT TTR amyloid formation after LT, which seems to be similar to the process in SSA. The truncation of TTR in amyloid deposits may depend on some genetic or environmental factors other than undergoing LT.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
0 Communities
1 Members
0 Resources
16 MeSH Terms
Re-evaluation of the indications for liver transplantation in Wilson's disease based on the outcomes of patients referred to a transplant center.
Ohya Y, Okajima H, Honda M, Hayashida S, Suda H, Matsumoto S, Lee KJ, Yamamoto H, Takeichi T, Mitsubuchi H, Asonuma K, Endo F, Inomata Y
(2013) Pediatr Transplant 17: 369-73
MeSH Terms: Adolescent, Adult, Chelating Agents, Child, Female, Follow-Up Studies, Hepatic Encephalopathy, Hepatolenticular Degeneration, Humans, Liver Failure, Acute, Liver Function Tests, Liver Transplantation, Male, Referral and Consultation, Treatment Outcome, Young Adult
Show Abstract · Added February 11, 2015
The aim of this study was to re-evaluate the indications and timing of LT for WD. From 2000 to 2009, eight patients with WD who had been referred to our institution for LT were enrolled in this study. The mean patient age was 15.9 yr (range, 7-37 yr). Four patients could not receive LT, because there were no available donors. All four patients were treated with chelating agent medication. Three of them (two of two patients with fulminant WD and one of two with cirrhotic WD) who did not undergo LT are still alive and doing well with stable liver functional tests. Only one of the patients with cirrhotic WD who did not undergo LT died of hepatic failure. Even among the four patients who underwent LT, one with fulminant WD recovered from hepatic encephalopathy with apheresis therapy and chelating agent. He later required LT because of severe neutropenia from d-penicillamine. The other three patients who underwent LT recovered and have been doing well. Some of the patients with WD can recover and avoid LT with medical treatment. Even when WD has progressed liver cirrhosis and/or fulminant hepatic failure at the time of diagnosis, medical treatment should be tried before considering LT.
© 2013 John Wiley & Sons A/S.
0 Communities
1 Members
0 Resources
16 MeSH Terms
Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients.
Honda M, Asonuma K, Hayashida S, Suda H, Ohya Y, Lee KJ, Yamamoto H, Takeichi T, Inomata Y
(2013) Clin Transplant 27: 426-35
MeSH Terms: Adolescent, Adult, Aged, Cohort Studies, Diabetes Complications, Diabetes Mellitus, Female, Follow-Up Studies, Graft Rejection, Humans, Japan, Liver Diseases, Liver Transplantation, Living Donors, Male, Middle Aged, Prognosis, Risk Factors, Survivors, Young Adult
Show Abstract · Added February 11, 2015
With the increased number of long-term survivors after liver transplantation, new-onset diabetes after transplantation (NODAT) is becoming more significant in patient follow-up. However, the incidence of new-onset diabetes after living-donor liver transplantation (LDLT) has not been well elucidated. The aim of this study was to evaluate the incidence and risk factors for NODAT in adult LDLT recipients at a single center in Japan. A retrospective study was performed on 161 adult patients without diabetes who had been followed up for ≥three months after LDLT. NODAT was defined according to the 2003 American Diabetes Association/World Health Organization guidelines. The recipient-, donor-, operation-, and immunosuppression-associated risk factors for NODAT were assessed. Overall, the incidence of NODAT was 13.7% (22/161) with a mean follow-up of 49.8 months. In a multivariate analysis, the identified risk factors for NODAT were donor liver-to-spleen (L-S) ratio (hazard ratio [HR] = 0.022, 95% confidence interval [CI] = 0.001-0.500, p = 0.017), and steroid pulse therapy for acute rejection (HR = 3.320, 95% CI = 1.365-8.075, p = 0.008). In conclusion, donor L-S ratio and steroid pulse therapy for acute rejection were independent predictors for NODAT in LDLT recipients. These findings can help in screening for NODAT and applying early interventions.
© 2013 John Wiley & Sons A/S.
0 Communities
1 Members
0 Resources
20 MeSH Terms
Peritransplant gastrointestinal symptoms in familial amyloidotic polyneuropathy.
Ohya Y, Isono K, Obayashi K, Hayashida S, Lee KJ, Yamamoto H, Takeichi T, Asonuma K, Ando Y, Inomata Y
(2013) Exp Clin Transplant 11: 327-31
MeSH Terms: Adult, Amyloid Neuropathies, Familial, Body Mass Index, Catheterization, Central Venous, Female, Gastrointestinal Diseases, Hospitals, University, Humans, Japan, Length of Stay, Liver Transplantation, Living Donors, Male, Middle Aged, Nutritional Status, Nutritional Support, Recovery of Function, Retrospective Studies, Time Factors, Treatment Outcome
Show Abstract · Added February 11, 2015
OBJECTIVES - Gastrointestinal dysfunction is a common complication in familial amyloidotic polyneuropathy, and gastrointestinal symptoms are associated with a patient's nutritional status. The object of this study was to evaluate changes in peritransplant gastrointestinal symptoms and the nutritional status of familial amyloidotic polyneuropathy patients using the modified body mass index following a living-donor liver transplant.
MATERIALS AND METHODS - In a retrospective analysis, we compared 17 Japanese familial amyloidotic polyneuropathy patients who underwent living-donor liver transplant in Kumamoto University Hospital between 2000 and 2009 with a control group of 28 patients with chronic liver disease. We analyzed the peritransplant gastrointestinal symptoms, nutritional status, duration of central venous catheterization, and postoperative hospital stay. The Mann-Whitney U test and Fisher exact test were used to analyze relations between the familial amyloidotic polyneuropathy group and control group, and the Wilcoxon signed-rank test, to analyze the relation of perioperative modified body mass index, with a value for P < .05 considered statistically significant.
RESULTS - The duration of central venous catheterization and postoperative hospital stay were significantly longer in the familial amyloidotic polyneuropathy group than they were in the control group. There was no significant difference between modified body mass index preoperatively and 1 year after living-donor liver transplant. Although gastrointestinal symptoms were typically mild before living-donor liver transplant, the familial amyloidotic polyneuropathy group experienced a temporary deterioration in gastrointestinal symptoms after receiving the living-donor liver transplant but recovered after approximately 2 months.
CONCLUSIONS - Although familial amyloidotic polyneuropathy patients experienced temporary exacerbations of gastrointestinal symptoms, their nutritional status was not affected during the peritransplant period, and they generally recovered within 2 months.
0 Communities
1 Members
0 Resources
20 MeSH Terms